Breathe Well Live Well
|
MediciNova Completes Enrollment in Phase 2 MN-221 Trial Treating Patients …
MarketWatch (press release) Patients suffering from acute exacerbations of asthma in the emergency room who were not promptly responding to standard pharmacotherapy were enrolled in the study. MediciNova is currently in the process of auditing and organizing the data and … |
View full post on asthma – Google News
|
Novartis launches Arcapta(TM) Neohaler(TM), a novel once-daily bronchodilator …
MarketWatch (press release) Arcapta Neohaler is not indicated to treat asthma. It is also not indicated to treat acute deteriorations of COPD and should not be used as a rescue medication for acute symptoms. Arcapta Neohaler is the only once-daily, 24-hour long-acting … |
View full post on asthma – Google News
|
petMD Warns Pet Owners to Watch Out for Pet Poisons in Your Purse
MarketWatch (press release) Asthma Inhalers (albuterol): Asthma inhalers are commonly stored in purses for emergency use. When accidentally chewed and punctured by dogs, asthma inhalers can cause acute poisoning. Asthma inhalers often contain concentrated doses of beta-agonist … |
View full post on asthma – Google News
|
Boston Scientific Welcomes Positive Private Insurance Coverage Decisions for …
MarketWatch (press release) "These coverage policies support the CMS payment decisions announced earlier this year and further confirm bronchial thermoplasty as a promising new advancement in the treatment of severe asthma." Bronchial thermoplasty delivered by the Alair System … |
View full post on asthma – Google News
|
UnitedHealthcare (UHC), the United States' Largest Private Health Insurer …
MarketWatch (press release) "We believe the positive change at UHC will improve clinical practice and health economic outcomes for asthma management." Asthma is one of this world's most common and costly diseases, affecting 8-10% of the population and costing over $50B annually … |
View full post on asthma – Google News
|
KALBITOR(R) (ecallantide) Data Presented at American Academy of Allergy …
MarketWatch (press release) (NASDAQ:DYAX) today announced the presentation of data from KALBITOR(R) (ecallantide) clinical studies in hereditary angioedema (HAE) at the American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting in Orlando, Florida. |
View full post on asthma – Google News
|
Dr. Lynn M. Taussig Named Chairman of iSonea's Medical Advisory Board
MarketWatch (press release) The mission of the MAB is to advise iSonea on clinical studies related to the commercial development of its Acoustic Respiratory Monitoring(TM) (ARM) devices and mobile health applications for the management of asthma and related respiratory disorders. |
View full post on asthma – Google News
|
Kaiser Permanente Study Finds Obesity-Asthma Link in Children Varies by Race …
MarketWatch (press release) 27, 2012 /PRNewswire via COMTEX/ — Children and adolescents who are overweight or obese are more likely to have asthma than their healthy weight counterparts, according to a new Kaiser Permanente Southern California study published in the online … |
View full post on asthma – Google News
|
New Book About Asthma Released by Dr. Gary Epler
MarketWatch (press release) BOSTON, Feb 14, 2012 (BUSINESS WIRE) — World-renowned Harvard Medical School pulmonary and critical care consultant Dr. Gary Epler extends his critically-acclaimed five-step method for personalized health to asthma with his new book, Asthma: You're … |
View full post on asthma – Google News
|
University Teams Tap Mobile Phones and Social Networks to Fight Non …
MarketWatch (press release) 9, 2012 /PRNewswire via COMTEX/ — New solutions developed by university teams could soon be harnessed to help manage the growing global problem of non-communicable diseases (NCDs) such as asthma, diabetes, stroke and cancer. |
View full post on asthma – Google News